Haleon PLC American Depositary Shares (Each Representing Two Ordinary Shares) (HLN) closed at $9.08 on November 18, 2026, up 0.3% from the previous close, on volume of 18,865,226 shares (30-day average 19,933,034).
Data as of November 18, 2026.
Haleon’s New Pain-Relief Study Offers Early Consumer Insight, but Limited Near-Term Stock Impact
TipRanks (Tue, 17-Nov 11:31 AM ET)
Barclays Reaffirms Their Buy Rating on Haleon PLC (HLN)
TipRanks (Tue, 17-Nov 3:15 AM ET)
Haleon Announces Purchase of 11 Million Shares Under Buyback Programme
TipRanks (Mon, 16-Nov 7:19 AM ET)
Haleon Launches 'Haleon Health House,' a One-Day Interactive Wellness Pop-Up in Toronto
Globe Newswire (Mon, 19-Oct 7:00 AM ET)
Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore
PRNewswire (Mon, 12-Oct 6:21 AM ET)
Globe Newswire (Wed, 9-Sep 7:00 AM ET)
Business Wire (Thu, 27-Aug 8:00 AM ET)
PRNewswire (Wed, 19-Aug 5:00 AM ET)
Sensodyne’s ‘World’s Coldest Treat’ Pop-Up Highlights HLN’s Focus on Everyday Oral Health Solutions
Market Chameleon (Thu, 6-Aug 4:21 AM ET)
Market Chameleon (Mon, 8-Jun 5:27 AM ET)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Haleon PLC American Depositary Shares (Each Representing Two Ordinary Shares) trades on the NYSE stock market under the symbol HLN.
As of November 18, 2026, HLN stock price climbed to $9.08 with 18,865,226 million shares trading.
HLN has a beta of -0.04, meaning it tends to be less sensitive to market movements. HLN has a correlation of 0.00 to the broad based SPY ETF.
HLN has a market cap of $39.80 billion. This is considered a Large Cap stock.
In the last 3 years, HLN traded as high as $11.42 and as low as $7.89.
The top ETF exchange traded funds that HLN belongs to (by Net Assets): PPH, AVDE, YLDE, AQEC, QLTI.
HLN has underperformed the market in the last year with a return of -4.2%, while SPY returned +10.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HLN shares. However, HLN has outperformed the market in the last 3 month and 2 week periods, returning -5.2% and +2.7%, while SPY returned -5.3% and -3.2%, respectively. This indicates HLN has been having a stronger performance recently.
HLN support price is $8.90 and resistance is $9.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HLN shares will trade within this expected range on the day.